The Novel Finding of Dynamic Change in eGFR Up to One Year after End of Treatment in HCV-Infected Patients Receiving Sofosbuvir and Velpatasvir

Background: The results of long-term renal evolution in HCV-infected patients using sofosbuvir and velpatasvir (SOF/VEL), with or without ribavirin (RBV), are lacking. Aims: We evaluated the renal safety for HCV-infected patients receiving SOF/VEL. Methods: Between 1 June 2019 and 6 July 2020, we in...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Cheng-Kun, Chen, Li-Wei, Chang, Te-Sheng, Tung, Shui-Yi, Lin, Chun-Yen, Hung, Chao-Hung, Lu, Sheng-Nan, Lin, Chih-Lang, Chen, Chien-Hung, Hsu, Chao-Wei, Hu, Tsung-Hui, Sheen, I-Shyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880184/
https://www.ncbi.nlm.nih.gov/pubmed/35215955
http://dx.doi.org/10.3390/v14020362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880184/
https://www.ncbi.nlm.nih.gov/pubmed/35215955
http://dx.doi.org/10.3390/v14020362

Ejemplares similares